# Delek Logistics Partners, LP: overview

DKL · NYSE · CIK 1552797 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dkl.md) · [Financials](/companies/dkl/financials.md) · [Filings](/companies/dkl/filings.md) · [Insiders](/companies/dkl/insiders.md)

Latest reported revenue: [$384.8m](/filings/0001628280-26-053097.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-053097).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [214](/filings/0001628280-25-050542.md) | [210 d](/filings/0001628280-26-012666.md) | [250](/filings/0001628280-26-028277.md) | [246](/filings/0001628280-26-053097.md) | [261](/filings/0001628280-25-050542.md) | [256 d](/filings/0001628280-26-012666.md) | [297](/filings/0001628280-26-028277.md) | [385](/filings/0001628280-26-053097.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [14.9%](/filings/0001628280-25-050542.md) | [18.1% d](/filings/0001628280-26-012666.md) | [19.0%](/filings/0001628280-26-028277.md) | [21.3%](/filings/0001628280-26-053097.md) | [17.4%](/filings/0001628280-25-050542.md) | [14.2% d](/filings/0001628280-26-012666.md) | [13.4%](/filings/0001628280-26-028277.md) | [16.1%](/filings/0001628280-26-053097.md) |
| Net margin | % | [15.7% d](/filings/0001628280-25-050542.md) | [16.8% d](/filings/0001628280-26-012666.md) | [15.6%](/filings/0001628280-26-028277.md) | [18.1% d](/filings/0001628280-26-053097.md) | [17.4% d](/filings/0001628280-25-050542.md) | [18.5% d](/filings/0001628280-26-012666.md) | [10.9%](/filings/0001628280-26-028277.md) | [7.5% d](/filings/0001628280-26-053097.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [(31.7) d](/filings/0001628280-25-050542.md) | [3.9 d](/filings/0001628280-26-012666.md) | [(23.9)](/filings/0001628280-26-028277.md) | [(7.1) d](/filings/0001628280-26-053097.md) | [(12.3) d](/filings/0001628280-25-050542.md) | [12.6 d](/filings/0001628280-26-012666.md) | [122](/filings/0001628280-26-028277.md) | [11.7 d](/filings/0001628280-26-053097.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [701](/filings/0001552797-24-000011.md) | [1,036](/filings/0001552797-25-000019.md) | [1,020](/filings/0001628280-26-012666.md) | [941](/filings/0001628280-26-012666.md) | [1,013](/filings/0001628280-26-012666.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [27.2%](/filings/0001552797-24-000011.md) | [20.2%](/filings/0001552797-25-000019.md) | [23.4%](/filings/0001628280-26-012666.md) | [21.6%](/filings/0001628280-26-012666.md) | [17.9%](/filings/0001628280-26-012666.md) |
| Net margin | % | [23.5%](/filings/0001552797-24-000011.md) | [15.3%](/filings/0001552797-25-000019.md) | [12.4%](/filings/0001628280-26-012666.md) | [15.2%](/filings/0001628280-26-012666.md) | [17.4%](/filings/0001628280-26-012666.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [252](/filings/0001552797-24-000011.md) | [51.1](/filings/0001552797-25-000019.md) | [129](/filings/0001628280-26-012666.md) | [77.3](/filings/0001628280-26-012666.md) | [(30.6)](/filings/0001628280-26-012666.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dkl/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2022-03-18 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 10,561 | $40.27 | $425.3k | [Form 4](/filings/0001694426-22-000079.md) |
| 2022-03-16 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 68 | $40.09 | $2.7k | [Form 4](/filings/0001694426-22-000077.md) |
| 2022-03-15 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 10,561 | $40.16 | $424.1k | [Form 4](/filings/0001694426-22-000077.md) |
| 2022-03-15 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 663 | $40.00 | $26.5k | [Form 4](/filings/0001694426-22-000077.md) |
| 2022-03-01 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 1,908 | $42.42 | $80.9k | [Form 4](/filings/0001694426-22-000054.md) |
| 2022-03-01 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 4,800 | $41.23 | $197.9k | [Form 4](/filings/0001694426-22-000054.md) |
| 2022-02-28 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 5,400 | $42.61 | $230.1k | [Form 4](/filings/0001694426-22-000054.md) |
| 2022-02-28 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 1,308 | $41.39 | $54.1k | [Form 4](/filings/0001694426-22-000054.md) |
| 2022-02-25 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 108 | $43.00 | $4.6k | [Form 4](/filings/0001694426-22-000054.md) |
| 2022-02-25 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 500 | $41.80 | $20.9k | [Form 4](/filings/0001694426-22-000054.md) |
| 2022-02-25 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 6,100 | $41.25 | $251.6k | [Form 4](/filings/0001694426-22-000054.md) |
| 2022-02-24 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 95 | $43.48 | $4.1k | [Form 4](/filings/0001694426-22-000045.md) |
| 2022-02-24 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 2,229 | $42.64 | $95.0k | [Form 4](/filings/0001694426-22-000045.md) |
| 2022-02-24 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 4,384 | $41.88 | $183.6k | [Form 4](/filings/0001694426-22-000045.md) |
| 2022-02-23 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 6,708 | $42.54 | $285.4k | [Form 4](/filings/0001694426-22-000045.md) |
| 2022-02-22 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 1,957 | $43.39 | $84.9k | [Form 4](/filings/0001694426-22-000045.md) |
| 2022-02-22 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 4,751 | $42.77 | $203.2k | [Form 4](/filings/0001694426-22-000045.md) |
| 2022-02-15 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 404 | $43.47 | $17.6k | [Form 4](/filings/0001694426-22-000036.md) |
| 2022-02-15 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 6,304 | $43.04 | $271.3k | [Form 4](/filings/0001694426-22-000036.md) |
| 2022-02-14 | [Delek US Holdings, Inc.](/insiders/1694426.md) | Director, 10% owner | Sale (S) | 108 | $43.32 | $4.7k | [Form 4](/filings/0001694426-22-000036.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ALPS ADVISORS INC](/funds/1376113.md) | 2026-06-30 | $226.0m | 4,384,141 |  | Reduced −191,526 |
| [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $84.0m | 1,630,692 |  | Added +32,990 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $78.1m | 1,515,208 |  | Added +16 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $27.2m | 528,545 |  | Added +428,181 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $25.3m | 490,801 |  | Reduced −150,634 |
| [Clearbridge Investments, LLC](/funds/1348883.md) | 2026-06-30 | $25.2m | 489,458 |  | Added +99,300 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $16.8m | 328,315 |  | Reduced −49,378 |
| [RAYMOND JAMES FINANCIAL INC](/funds/720005.md) | 2026-06-30 | $14.2m | 275,718 |  | Added +20,488 |
| [NEOS Investment Management LLC](/funds/2001019.md) | 2026-06-30 | $8.9m | 173,361 |  | Added +62,267 |
| [WESTWOOD HOLDINGS GROUP INC](/funds/1165002.md) | 2026-06-30 | $8.3m | 160,185 |  | Reduced −439 |

## Recent filings

[All 862 filings](/companies/dkl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:22 ET | [8-K](/filings/0001628280-26-067064.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-067064 |
| 2026-08-14 | 20:25 ET | [8-K](/filings/0001193125-26-352363.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-352363 |
| 2026-08-14 | 10:02 ET | [8-K](/filings/0001193125-26-350181.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-350181 |
| 2026-08-13 | 10:03 ET | [8-K](/filings/0001193125-26-347734.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-347734 |
| 2026-08-12 | 20:05 ET | [8-K](/filings/0001193125-26-346821.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-346821 |
| 2026-08-05 | 17:03 ET | [10-Q](/filings/0001628280-26-053097.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053097 |
| 2026-08-05 | 10:35 ET | [8-K](/filings/0001628280-26-052893.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052893 |
| 2026-07-22 | 20:42 ET | [8-K](/filings/0001628280-26-049217.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-049217 |
| 2026-05-14 | 20:06 ET | [8-K](/filings/0001193125-26-223986.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-223986 |
| 2026-05-05 | 23:31 ET | [8-K](/filings/0001193125-26-204602.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-204602 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-012666.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/62f6113d-7852-4e2c-b665-3ba83124cff5)

## About the filer

- CIK: 1552797
- Tickers: DKL
- Exchange: NYSE
- SIC code: 4610 Pipe Lines (No Natural Gas)
- State of incorporation: TN
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.